Barclays’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.58M | Buy |
984,512
+676,377
| +220% | +$2.46M | ﹤0.01% | 1838 |
|
|
2025
Q1 | $591K | Sell |
308,135
-67,360
| -18% | -$129K | ﹤0.01% | 2739 |
|
|
2024
Q4 | $713K | Buy |
375,495
+102,410
| +38% | +$194K | ﹤0.01% | 2840 |
|
|
2024
Q3 | $360K | Buy |
273,085
+200,482
| +276% | +$264K | ﹤0.01% | 3175 |
|
|
2024
Q2 | $74K | Sell |
72,603
-137,397
| -65% | -$140K | ﹤0.01% | 3512 |
|
|
2024
Q1 | $384K | Buy |
+210,000
| New | +$384K | ﹤0.01% | 2988 |
|
|
2022
Q2 | – | Sell |
-84,146
| Closed | -$61K | – | 4685 |
|
|
2022
Q1 | $61K | Sell |
84,146
-200,624
| -70% | -$145K | ﹤0.01% | 3914 |
|
|
2021
Q4 | $643K | Buy |
284,770
+96,413
| +51% | +$218K | ﹤0.01% | 2420 |
|
|
2021
Q3 | $542K | Buy |
188,357
+19,081
| +11% | +$54.9K | ﹤0.01% | 2570 |
|
|
2021
Q2 | $642K | Sell |
169,276
-67,942
| -29% | -$258K | ﹤0.01% | 2344 |
|
|
2021
Q1 | $804K | Buy |
237,218
+73,426
| +45% | +$249K | ﹤0.01% | 2413 |
|
|
2020
Q4 | $458K | Sell |
163,792
-20,701
| -11% | -$57.9K | ﹤0.01% | 2362 |
|
|
2020
Q3 | $463K | Buy |
184,493
+49,439
| +37% | +$124K | ﹤0.01% | 2341 |
|
|
2020
Q2 | $1.83M | Buy |
135,054
+1,297
| +1% | +$17.6K | ﹤0.01% | 1534 |
|
|
2020
Q1 | $1.01M | Sell |
133,757
-37,133
| -22% | -$282K | ﹤0.01% | 1712 |
|
|
2019
Q4 | $1.08M | Buy |
170,890
+51,902
| +44% | +$328K | ﹤0.01% | 2248 |
|
|
2019
Q3 | $467K | Sell |
118,988
-10,615
| -8% | -$41.7K | ﹤0.01% | 2645 |
|
|
2019
Q2 | $628K | Buy |
129,603
+20,912
| +19% | +$101K | ﹤0.01% | 2601 |
|
|
2019
Q1 | $891K | Buy |
108,691
+106,653
| +5,233% | +$874K | ﹤0.01% | 2228 |
|
|
2018
Q4 | $11K | Sell |
2,038
-93,007
| -98% | -$502K | ﹤0.01% | 3515 |
|
|
2018
Q3 | $839K | Buy |
95,045
+80,240
| +542% | +$708K | ﹤0.01% | 2359 |
|
|
2018
Q2 | $148K | Sell |
14,805
-16,340
| -52% | -$163K | ﹤0.01% | 2904 |
|
|
2018
Q1 | $296K | Buy |
31,145
+13,161
| +73% | +$125K | ﹤0.01% | 2612 |
|
|
2017
Q4 | $268K | Buy |
17,984
+16,416
| +1,047% | +$245K | ﹤0.01% | 2481 |
|
|
2017
Q3 | $30K | Sell |
1,568
-12,330
| -89% | -$236K | ﹤0.01% | 3097 |
|
|
2017
Q2 | $199K | Buy |
13,898
+13,020
| +1,483% | +$186K | ﹤0.01% | 2430 |
|
|
2017
Q1 | $9K | Sell |
878
-3,174
| -78% | -$32.5K | ﹤0.01% | 3546 |
|
|
2016
Q4 | $43K | Buy |
4,052
+3,704
| +1,064% | +$39.3K | ﹤0.01% | 2883 |
|
|
2016
Q3 | $3K | Sell |
348
-145
| -29% | -$1.25K | ﹤0.01% | 3499 |
|
|
2016
Q2 | $4K | Buy |
493
+300
| +155% | +$2.43K | ﹤0.01% | 3144 |
|
|
2016
Q1 | $2K | Sell |
193
-266
| -58% | -$2.76K | ﹤0.01% | 3196 |
|
|
2015
Q4 | $6K | Sell |
459
-7,918
| -95% | -$104K | ﹤0.01% | 2875 |
|
|
2015
Q3 | $75K | Buy |
8,377
+7,854
| +1,502% | +$70.3K | ﹤0.01% | 2460 |
|
|
2015
Q2 | $6K | Buy |
523
+49
| +10% | +$562 | ﹤0.01% | 3503 |
|
|
2015
Q1 | $5K | Buy |
474
+29
| +7% | +$306 | ﹤0.01% | 3638 |
|
|
2014
Q4 | $4K | Buy |
445
+364
| +449% | +$3.27K | ﹤0.01% | 3950 |
|
|
2014
Q3 | $2K | Sell |
81
-2,400
| -97% | -$59.3K | ﹤0.01% | 4113 |
|
|
2014
Q2 | $67K | Buy |
+2,481
| New | +$67K | ﹤0.01% | 2920 |
|